---
category: news
title: "COVID Treatments: Gilead Stock Doesnâ€™t Reflect Optimism About Remdesivir"
excerpt: "Gilead received U.S. FDA authorization for emergency use of its wide-spectrum anti-viral drug Remdesivir for severe cases of COVID-19 after the drug showed some effectiveness in reducing recovery times."
publishedDateTime: 2020-05-08T12:01:00Z
webUrl: "https://www.forbes.com/sites/greatspeculations/2020/05/08/covid-treatments-gilead-stock-doesnt-reflect-optimism-about-remdesivir/"
ampWebUrl: "https://www.forbes.com/sites/greatspeculations/2020/05/08/covid-treatments-gilead-stock-doesnt-reflect-optimism-about-remdesivir/amp/"
cdnAmpWebUrl: "https://www-forbes-com.cdn.ampproject.org/c/s/www.forbes.com/sites/greatspeculations/2020/05/08/covid-treatments-gilead-stock-doesnt-reflect-optimism-about-remdesivir/amp/"
type: article
quality: 99
heat: 99
published: false

provider:
  name: Forbes
  domain: forbes.com
  images:
    - url: "https://insideout.app/coronavirus/assets/images/organizations/forbes.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - Treatment
  - Coronavirus

secured: "FqA2H3tOy38gQEqv+0k8fjyFlCDPOQMKQZjIUzAR1qT6w4OgRkp93mRViXYy+QthmZf0Wa5RGWrvgm15KBNNC4NYwfA2iby+2VG1IGwhza4kdjf9Ht3TQ66Bb4GWuEVRQrST6NWmMRxExcaDgJ/s0Mh7uRZuo7XmgkEEiw+uxsd+Gz0qmUr+cXMO8utOZG7eoXoRfdb29Q1u+74m8FTdiWQ9SdHk0H7iUT+vMy1AZgMPqWtLrlnl9x8U/nsAGUksCeFsn3li344aO1XsRakimPnTLGcs3KD1hU59pyEWQDxSzZwIdz5S0+0l8ULqSw3g7Qd9Rdce1l/YlCG51f8ZPVjAdeAxCJAC5l8nE8yZ10vKOGT2izJIvXnxGIdl5NEfNyqUbDEgsCHfNS8zHwDOcWnSQcOEWmWHcfjU1eX6DP638JEb6XJRGf/DXSe3bDct2ZRgTTE6tmA7bMWT1WXkR5vPm44bVkW42Lj/uHxWhBw=;VCCn9iPMtXoniVyG9WiZ7Q=="
---

